Coronavirus India LIVE updates: The Assam doctor, who was detected with both the Alpha and Delta variants of coronavirus, was fully vaccinated, according to officials.
Coronavirus India Live Updates: India recorded 42,015 new coronavirus cases and 3,998 deaths in the last 24 hours ending at 8 am on Wednesday. With this, total cases have risen to 3,12,16,337. Nearly 37,000 recoveries were reported yesterday, as per the Union Health Ministry. The daily positivity rate at 2.27 per cent, less than 3 per cent for 30 consecutive days.
A doctor in Assam was found to be infected by two different coronavirus variants of concern, both Alpha and Delta. But her condition is nothing to be alarmed about, according to officials.
“It will be similar to any other mono-infection of the virus, nothing to worry that the dual infection will cause the severe disease, it is not like that,” Dr. BJ Borkakoti, Senior Scientist, Regional Medical Research Centre, Dibrugarh, told ANI.
No death due to lack of oxygen has been specifically reported by the states and union territories, Union Minister of State for Health and Family Welfare Bharati Pravin Pawar informed Rajya Sabha on Tuesday. The government, however, said there was “unprecedented surge” in demand of medical oxygen during the second wave of Covid-19.
Meanwhile, Muslims across the country are observing the annual festival of Eid al-Adha or Eid-ul-Adha under the shadow of the Covid pandemic. Officials have urged devotees to celebrate while observing appropriate Covid protocols.
India records 42,015 new coronavirus cases, 3,998 deaths; Assam doctor infected with Alpha and Delta variants of coronavirus simultaneously. Follow this space for the latest updates on India’s Covid-19 outbreak.
Union Health Minister Mansukh Mandaviya on Tuesday told Rajya Sabha that India will be the first country to develop a DNA-based Covid-19 vaccine even as other manufactures are steadily ramping up production.
“It is a matter of great pride for us that our scientists will be the first to develop a DNA vaccine,” the minister said, referring to Zydus Cadila, which has applied for emergency use authorisation of its DNA vaccine.
Mandaviya said while Serum Institute of India has begun providing 11-12 crore doses of Covishied vaccine every month, Biological E is conducting third-phase trial of its vaccine, which is expected to come in the market by September-October with 7.5 crore doses. Read the full report here.
In a rare outburst from a government official, Telangana’s Director of Public Health G Srinivasa Rao on Tuesday censured political leaders of all hues for violating Covid-19 protocols and putting the lives of the people in danger, and negating gains made by the state’s health officials in containing the spread of the pandemic.
Rao, who is often praised for his handling of the pandemic in Telangana, said while political leaders think they are doing their job in a democracy, they are also putting lives of their party workers, supporters, and general public at risk by not adhering to the Covid rules and restrictions.
“Elections in the state are still two-and-half years away but leaders of all political parties are behaving as if elections are due shortly. They are holding rallies, party workers’ meetings and public functions, and opposition parties are holding dharnas and protests without any care. It is an invitation to the third wave of Covid-19,” Rao told reporters. Read the full report here.
Up to two-thirds of the Indian population above the age of six have already been infected with the coronavirus, the latest nationwide serological survey conducted by the Indian Council of Medical Research (ICMR) has found. That still leaves about 40 crore people who are susceptible to the virus.
The serosurvey, the fourth such exercise, was conducted in June and July, after the second wave had began to subside. A total of 28,975 people were tested for the presence of antibodies specific to SARS-CoV2 virus, and 67.6% were found to have them. For the first time, minors in the age group of 6 to 17 years were also included in the serosurvey, with antibodies interestingly discovered in nearly half of them. Read the full report here.
India recorded 42,015 new coronavirus cases and 3,998 deaths in the last 24 hours ending at 8 am on Wednesday. With this, total cases have risen to 3,12,16,337. Nearly 37,000 recoveries were reported yesterday, as per the Union Health Ministry. The daily positivity rate at 2.27 per cent, less than 3 per cent for 30 consecutive days.
Active cases show a rise, from 4.06 lakh on Monday to 4.07 lakh on Tuesday. In Kerala, there are more than 1.26 lakh active cases now.
Of the 3,998 deaths reported on Tuesday, Maharashtra reported more than 3,650 in another data cleaning exercise that added previously uncounted deaths.
Bengaluru: Passengers wear face masks for prevention against COVID-19, at Sangolli Rayanna railway station in Bengaluru, Thursday, July 15, 2021. (PTI Photo/Shailendra Bhojak)
Prime Minister Narendra Modi on Tuesday apprised the floor leaders of both Houses on Covid-19 situation and said that “pandemic should not be a matter of politics and is a matter of concern for entire humanity,” a statement from the Ministry of Parliamentary Affairs stated. PM also stressed the need to properly plan the vaccination drives at the district level based on the advance availability information.
Earlier in the day, the ICMR said that it would be wise to consider reopening primary schools first as children can handle viral infection much better. In the latest national sero survey conducted by ICMR in June-July, one third of the population did not have SARS-CoV-2 antibodies meaning that about 40 crore people still vulnerable to Covid-19 infection. The government further said that 67.6% of India’s population above 6 years have been found to have SARS-CoV-2 antibodies and that 85 per cent of surveyed healthcare workers had antibodies against SARS-CoV-2 while one-tenth of HCWs still unvaccinated.
Meanwhile, four Covid-19 vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Union Science and Technology Minister Jitendra Singh said on Tuesday in a written response to a question in the Rajya Sabha, news agency PTI reported.
He said that Cadila Healthcare Ltd’s DNA-based vaccine candidate is in phase three clinical trial and it has also submitted the interim data for emergency use authorisation. Biological E Ltd’s vaccine candidate is also in phase three clinical trial. Bharat Biotech International Ltd’s Adeno intranasal vaccine candidate is in phase three clinical trial, while Gennova Biopharmaceuticals Ltd’s mRNA-vaccine candidate is in Phase one clinical trial. The Gurgaon-based Genique Life Sciences Pvt Ltd’s vaccine candidate is in the advanced pre-clinical stage, he added.
Source: Read Full Article